Skip to main content

Table 2 Patient characteristics

From: Effects of localisation of uterine adenomyosis on outcome of in vitro fertilisation/intracytoplasmic sperm injection fresh and frozen-thawed embryo transfer cycles: a multicentre retrospective cohort study

 

Advanced group (n = 40)

Extrinsic group (n = 9)

Intrinsic group (n = 3)

P-value

Age (years)

36 (26–41)

37 (30–39)

35 (31–36)

0.403

Body mass index (kg/m 2 )

23 (18.1–32.5)

19.9 (18.1–23.3)

23.5 (19.5–25.8)

0.018

Duration of infertility (months)

41.5 (6–151)

42 (0–66)

45 (31–90)

0.519

Cause of infertility, n (%)

   

0.092

Endometriosis

24 (60)

4 (44.4)

0

 

Tubal

2 (5)

1 (11.1)

0

 

Anovulation

0

0

1 (33.3)

 

Mixed

9 (22.5)

3 (33.3)

1 (33.3)

 

Unexplained

5 (12.5)

1 (11.1)

1 (33.3)

 

Gravidity, n (%)

17/40 (42.5)

4/9 (44.4)

2/3 (66.7)

0.879

Parity, n (%)

7/40 (0–1)

3/9 (0–1)

0

0.411

Miscarriage, n (%)

13/40 (32.5)

1/9 (11.1)

2/3 (66.7)

0.199

Prior IVF/ICSI-ET treatment cycle

0 (0–9)

0 (0–8)

0 (0–6)

0.933

Prior uterine surgery, n (%)

6/40 (15)

2/9 (22.2)

0

0.777

Prior surgery for endometrioma, n (%)

13/40 (32.5)

7/9 (77.8)

1/3 (33.3)

0.035

Presence of endometrioma, n (%)

28/40 (70)

9/9 (100)

0

0.004

Hypermenorrhoea, n (%)

28/40 (70)

5/9 (55.5)

1/3 (33.3)

0.324

Dysmenorrhoea, n (%)

35/40 (87.5)

7/9 (77.8)

2/3 (66.7)

0.354

  1. IVF/ICSI-ET in vitro fertilisation/intracytoplasmic sperm injection-embryo transfer